USFDA APPLICATION NUMBER - 50684 / DOSAGE - INJECTABLE;INJECTION - EQ 4GM BASE/VIAL;EQ 500MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Active Ingredient/Active Moiety | ||
Ingredient Name | Basis of Strength | Strength |
---|---|---|
PIPERACILLIN SODIUM(UNII: M98T69Q7HP) (PIPERACILLIN - UNII:X00B0D5O0E) | PIPERACILLIN | 3.0g in 15 |
TAZOBACTAM SODIUM(UNII: UXA545ABTT) (TAZOBACTAM - UNII:SE10G96M8W) | TAZOBACTAM | 0.375g in 15 |
Inactive Ingredients
Ingredient Name | Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc. | Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc. | Cardinal Health | Wyeth Piperacillin Division of Wyeth Holdings Corporation, a subsidiary of Pfizer |
---|---|---|---|---|
DEXTROSE MONOHYDRATE(LX22YL083G) | ||||
EDETATE DISODIUM(7FLD91C86K) | ||||
HYDROCHLORIC ACID(QTT17582CB) | ||||
SODIUM BICARBONATE(8MDF5V39QO) | ||||
SODIUM CITRATE(1Q73Q2JULR) | ||||
SODIUM CITRATE, UNSPECIFIED FORM(1Q73Q2JULR) | ||||
WATER(059QF0KO0R) |
LOOKING FOR A SUPPLIER?